Alexandria Pharmaceuticals Net Profit 8.4% Up In July

Alexandria Pharmaceutical and Chemical Industries (AXPH.CA) reported a net profit of EGP 4.673 million through July 2012, 8.4% up from a year earlier net profit of EGP 4.309 million.
Alexandria Pharmaceutical board of directors approved on the beginning of August to ratify the financial statements for the first half of 2012 which revealed a net profit of EGP 44.26 million 6.6% less than a net profit of EGP 47.365 million posted a year earlier.

Worth mentioning, the issued capital valued at EGP 45 million distributed to 4.5 million securities in which the par value amounts to EGP 10 per share.